Skip to search formSkip to main contentSkip to account menu

bucillamine

Known as: tiobutarit, N-(2-mercapto-2-methylpropionyl)-L-cysteine, 2-mercapto-2-methylpropanoyl-L-cysteine 
National Institutes of Health

Related topics

Related topics

5 relations

Broader (3)

Anti-Inflammatory Agents, Non-SteroidalAntioxidantsCysteine

Narrower (1)

SA 96
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
The ability of disease modifying antirheumatic drugs to induce and maintain improvement in patients with rheumatoid arthritis. epidemiology of DMARDs treatment in Japan.
OBJECTIVE The effectiveness of the disease-modifying antirheumatic drugs (DMARDs) methotrexate (MTX), bucillamine (BUC… 
2002
2002
Usefulness of three-drug additional combination therapy with bucillamine, sulfasalazine and methotrexate for refractory rheumatoid arthritis
To determine the efficacy of three-drug additional combination therapy for refractory rheumatoid arthritis (RA), we enrolled… 
1996
1996
Effect if bucillamine on the rat trinitrobenzene sulfonic acid induced model of colitis
Salicylazosulphapyridine and corticosteroids are the only remedies for inflammatory bowel disease currently in clinical use. They… 
1995
1995
Rheumatoid arthritis exacerbation by G-CSF treatment for bucillamine-induced agranulocytosis.
1994
1994
Bucillamine may be an effective anti-rheumatic drug in patients with end-stage renal disease A case report
ブシラミンは, 日本で開発された遅効性抗リウマチ薬であるが, 腎排泄性であり腎不全症例への投与は禁忌とされてきた. 今回, 我々は維持透析へ導入後もコントロール困難な関節痛に悩む慢性関節リウマチの1… 
1994
1994
Anti-inflammatory effect of bucillamine on carrageenan-induced colitis in the rabbit
1993
1993
Long-term bucillamine administration in rheumatoid arthritis ; results of 5-year administration and prediction of its efficacy at initiation of treatment.
This study had two purposes; to assess the results of 5-year administration of bucillamine (Bc), and to see the predictability of… 
Review
1991
Review
1991
"Yellow nail syndrome" and rheumatoid arthritis.
A nail dystrophy characterized by the slow growth of nails and their yellowish discoloration, the so-called yellow nail syndrome… 
1991
1991
Bucillamine may induce myasthenia gravis.
To the editor: A patient with a high serum growth hormone(GH) level which seemed to be induced by dihydroergotamine (DHE) is… 
1987
1987
Bucillamine: a new immunomodulator
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)